Get the Stockscreener App
269.75
1.34%
-3.65
After Hours:
270.70
0.95
+0.35%
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $269.75, with a volume of 2.29M.
It is down -1.34% in the last 24 hours and down -17.71% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$273.40
Open:
$273.22
24h Volume:
2.29M
Relative Volume:
0.88
Market Cap:
$103.47B
Revenue:
$25.27B
Net Income/Loss:
$3.34B
P/E Ratio:
31.24
EPS:
8.6334
Net Cash Flow:
$4.57B
1W Performance:
-3.71%
1M Performance:
-17.71%
6M Performance:
-17.89%
1Y Performance:
-27.33%
1-Day Range:
$269.73
$275.71
1-Week Range:
$269.73
$279.26
52-Week Range:
$267.00
$392.55
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
269.75 | 104.87B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
101.07 | 179.08B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.51 | 114.23B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
44.68 | 64.66B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.73 | 50.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Leerink Partners | Outperform |
| Feb-20-26 | Initiated | William Blair | Outperform |
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp.SYK - PR Newswire
Stryker Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Under a matrimonial settlement, Stryker (SYK) CFO Wells Preston Wendell transferred shares twice. - Stock Titan
QRG Capital Management Inc. Decreases Holdings in Stryker Corporation $SYK - MarketBeat
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now? - The Globe and Mail
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now? - Zacks Investment Research
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now - Your Wyoming Link
Stryker stock steadies after target cuts and earnings gains - ad-hoc-news.de
Stryker stock heads into the open after a 0.33 percent gain - ad-hoc-news.de
Stryker stock falls 21.6 percent as TD Cowen cuts target - ad-hoc-news.de
Stryker Corporation $SYK Shares Bought by State Street Corp - MarketBeat
Stryker (SYK) Foot And Ankle Push Keeps Undervalued Narrative In Focus - Yahoo Finance
Stryker (SYK) Expanded Its Foot And Ankle Portfolio - finance.yahoo.com
TD Cowen cuts Stryker stock price target to $298 on margin concerns - Investing.com
Jefferies Adjusts Price Target on Stryker to $405 From $440, Keeps Buy Rating - marketscreener.com
Stryker stock before the bell after a 0.36 percent drop - ad-hoc-news.de
Stryker (SYK): The Healthcare Stocks Name Everyone's Asking About - Kalkine Media
Stryker stock gains from Raymond James support - ad-hoc-news.de
Stryker Corp. stock heads into the open without fresh session data - ad-hoc-news.de
Stryker Corp. stock holds steady amid lack of fresh data - ad-hoc-news.de
Stryker Corp. stock underperforms Friday when compared to competitors - MarketWatch
Securities firm investigates Stryker for possib... - Pluang
Stryker (NYSE:SYK) Given New $385.00 Price Target at Canaccord Genuity Group - MarketBeat
Stryker Is Maintained at Buy by Canaccord Genuity - Moomoo
Nykredit A S Purchases Shares of 282,407 Stryker Corporation $SYK - MarketBeat
Canaccord cuts Stryker stock price target on manufacturing woes By Investing.com - Investing.com Nigeria
Canaccord cuts Stryker stock price target on manufacturing woes - Investing.com
Stryker Expands Foot & Ankle Innovation With Prophecy and smartHEX - Yahoo Finance
RBC Capital Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $420 - Moomoo
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker showcases Foot & Ankle innovation at AOFAS 2026 with Prophecy® Surgical Planning for Incompass™ and Hoffmann® LRF smartHEX™ - Yahoo! Finance Canada
BofA Securities Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $380 - Moomoo
Stryker (SYK) Stock Still Looks Cheap On Its 24% Slide - finance.yahoo.com
Stryker Corp rStock (RSYK) Price Prediction for 2026 to 2031 - bybit.com
Stryker Corp. stock extends slide as analysts trim targets but keep buy ratings - ad-hoc-news.de
Law firm probes Stryker for possible securities law breaches after conflicting manufacturing updates. - Pluang
Stryker stock heads into the open after a 1.95% drop - ad-hoc-news.de
Stryker stock falls on slower peripheral vascular, hip sales - MedTech Dive
Stryker Corporation $SYK Shares Acquired by Tidal Investments LLC - MarketBeat
WINTON GROUP Ltd Grows Position in Stryker Corporation $SYK - MarketBeat
BMO cuts Stryker stock price target on revised estimates to $317 By Investing.com - Investing.com Australia
NJ Electrical Manufacturer Taps Longtime Stryker Atty As GC - Law360
BMO cuts Stryker stock price target on revised estimates to $317 - Investing.com Nigeria
BMO Capital Maintains Stryker Corp(SYK.US) With Buy Rating, Cuts Target Price to $317 - Moomoo
Stryker To Acquire ZuriMED To Expand Shoulder And Rotator Cuff Portfolio - Pulse 2.0
Stryker acquires Swiss firm to expand shoulder repair business - Crain's Grand Rapids
Citigroup Adjusts Stryker Price Target to $360 From $399, Maintains Buy Rating - marketscreener.com
Is Stryker (NYSE:SYK) a stock worth watching as trading resumes? - Kalkine Media
Wells Fargo cuts Stryker stock price target on revenue concerns By Investing.com - Investing.com India
Stryker Stock Drops Over 7% As Supply Chain Constraints Impact Peripheral Vascular Business - TIKR.com
Duke Health, Stryker put augmented reality to work in hip surgery - modernhealthcare.com
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):